Related Experiment Video
Updated: Jan 30, 2026

Isolation Method for Long-Term and Short-Term Hematopoietic Stem Cells
Published on: May 19, 2023
Single-Molecule hsTnI and Short-Term Risk in Stable Patients With Chest Pain
James L Januzzi1, Sunil Suchindran2, Udo Hoffmann3
1Cardiology Division, Massachusetts General Hospital, Boston, Massachusetts; Baim Institute for Clinical Research, Boston, Massachusetts.
Insights
High-sensitivity troponin I (hsTnI) levels within the normal range can predict near-term cardiac events in patients with suspected coronary artery disease (CAD). This troponin testing aids in assessing risk for death or myocardial infarction (MI).
Area of Science:
- Cardiology
- Biomarker Research
- Clinical Diagnostics
Background:
- Evaluating stable outpatients with suspected coronary artery disease (CAD) presents challenges due to varied cardiovascular risk.
- The utility of troponin testing in this specific clinical setting remains largely unexplored.
Purpose of the Study:
- To investigate the prognostic value of single-molecule counting high-sensitivity troponin I (hsTnI) in outpatients with stable chest symptoms and suspected CAD.
- To determine if hsTnI levels, even within the normal range, can predict adverse cardiovascular outcomes.
Main Methods:
- Analysis of hsTnI results from 4,021 participants in the PROMISE study with available blood samples.
- hsTnI levels were assessed against the primary outcome of death, acute myocardial infarction (MI), or hospitalization for unstable angina within one year.
- Multivariable models were used to evaluate hsTnI as an independent predictor of outcomes.
Main Results:
- A median hsTnI value of 1.6 ng/L was observed, with measurable concentrations in 98.6% of participants.
- Higher hsTnI concentrations, even within the normal range (<6 ng/L), were associated with increased risk of major adverse cardiovascular events.
- hsTnI independently predicted death, MI, or hospitalization (HR 1.54) and cardiovascular death or MI (HR 1.52), particularly for near-term events.
Conclusions:
- Elevated hsTnI levels within the normal range are linked to increased near-term risk of adverse cardiovascular events in symptomatic outpatients with suspected CAD.
- hsTnI testing can provide valuable prognostic information for risk stratification in this patient population.
Background:
Evaluation of stable symptomatic outpatients with suspected coronary artery disease (CAD) may be challenging because they have a wide range of cardiovascular risk. The role of troponin testing to assist clinical decision making in this setting is unexplored.
Objectives:
This study sought to evaluate the prognostic meaning of single-molecule counting high-sensitivity troponin I (hsTnI) (normal range <6 ng/l) among outpatients with stable chest symptoms and suspected CAD.
Methods:
Participants with available blood samples in PROMISE (Prospective Multicenter Imaging Study for Evaluation of Chest Pain) were studied, and hsTnI results were analyzed relative to the primary outcome of death, acute myocardial infarction (MI), or hospitalization for unstable angina by 1 year. The secondary outcome was the composite of cardiovascular death or acute MI.
Results:
The study sample consisted of 4,021 participants; 98.6% had measurable hsTnI concentrations. The median hsTnI value was 1.6 ng/l. In upper hsTnI quartiles, patients had higher-risk clinical profiles. Higher hsTnI concentrations were associated with greater event probabilities for death, acute MI, or hospitalization for unstable angina. In multivariable models, hsTnI concentrations independently predicted death, acute MI, or hospitalization for unstable angina (hazard ratio: 1.54 per increase in log-hsTnI interquartile range; p < 0.001) and cardiovascular death or acute MI (hazard ratio: 1.52 per increase in log-hsTnI interquartile range; p < 0.001) and were particularly associated with near-term events, compared with longer follow-up.
Conclusions:
In symptomatic outpatients with suspected CAD, higher concentrations of hsTnI within the normal range were associated with heightened near-term risk for death, acute MI, or hospitalization. (Prospective Multicenter Imaging Study for Evaluation of Chest Pain [PROMISE]; NCT01174550).
More Related Videos
Related Concept Videos
Flail Chest-I
Flail chest is a severe and potentially life-threatening condition characterized by the fracture of three or more adjacent ribs in multiple places. It is most commonly caused by direct impacts and trauma, such as motor vehicle accidents or injuries from a steering wheel impact. It can also occur due to falls in elderly individuals with osteoporosis, or assaults involving sharp objects.
Pathophysiology
The pathophysiology of flail chest is complex, involving fractures of...
Flail Chest-II
Assessment:
1. Clinical Evaluation:
History:
Chest Physiotherapy
Purpose
CPT is primarily used for patients with excessive bronchial secretions who have difficulty clearing...
Molecules and Compounds
Relative Risk
Long-term Depression

